Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Planta Medica|May 21, 2020
Characterization of Maca (Lepidium meyenii/Lepidium peruvianum) Using a Mass Spectral Fingerprinting, Metabolomic Analysis, and Genetic Sequencing ApproachPing Geng, Jianghao Sun, Pei Chen, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
Evolutionary arms race between SARS-CoV-2 and interferon signaling via dynamic interaction with autophagyJae Seung Lee, Mark Dittmar, Jesse Miller, et al.
Cell Reports|December 21, 2024
Pressure to evade cell-autonomous innate sensing reveals interplay between mitophagy, IFN signaling, and SARS-CoV-2 evolutionJae Seung Lee, Mark Dittmar, Jesse Miller, et al.
Mbio|June 28, 2023
SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infectionMinghua Li, Kasirajan Ayyanathan, Mark Dittmar, et al.
Plos Pathogens|February 17, 2026
NS5-targeting nucleoside analogs inhibit dengue virus and other flavivirusesPriyanka Bhakt, Swechha M Pokharel, Yue Li, et al.
Biorxiv : the Preprint Server for Biology|June 30, 2021
Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infectionDavid C Schultz, Robert M Johnson, Kasirajan Ayyanathan, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
Modeling SARS-CoV-2 and Influenza Infections and Antiviral Treatments in Human Lung Epithelial Tissue EquivalentsHoda Zarkoob, Anna Allué-Guardia, Yu-Chi Chen, et al.
Plos One|March 25, 2025
Assessment of three large-scale depopulation methods for swineJanice Y Park, Magnus R Campler, Ting-Yu Cheng, et al.
Nature|February 7, 2022
Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2David C Schultz, Robert M Johnson, Kasirajan Ayyanathan, et al.
Communications Biology|August 12, 2022
Modeling SARS-CoV-2 and influenza infections and antiviral treatments in human lung epithelial tissue equivalentsHoda Zarkoob, Anna Allué-Guardia, Yu-Chi Chen, et al.
Pageof 3